References
- World Health Organization. Mortality Report. Geneva: WHO; 2002. Available from: http://www.who.org (Accessed 14 December 2011).
- Alanis AJ. Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res. 2005;36:697–705.
- Nordmann P, Naas T, Fortineau N, Poirel L. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr Opin Microbiol. 2010;10:436–40.
- Wahdan HA. Causes of the antimicrobial activity of honey. Infection. 1998;26:26–31.
- Hart GD. Asclepius: the god of medicine. London: The Royal Society of Medicine Press; 2000.
- Birch B, Fleming A. Alexander Fleming: pioneer with antibiotics. Farmington Hills, MI: Greenhaven Press; 2002.
- Bankston J. Gerhard Domagk and the discovery of sulfa. Hockessin, DE: Mitchell Lane Publishers; 2002.
- Waksman SA. My life with the microbes. New York: Simon and Schuster; 1954.
- Fayerman JT. Second-generation products: antibiotics. Bioprocess Technol. 1991;13:415–24.
- Goto H, Shimada K, Ikemoto H, Oguri T; Study Group on Antimicrobial Susceptibility of Pathogens Isolated from Respiratory Infections. Antimicrobial susceptibility of pathogens isolated from more than 10,000 patients with infectious respiratory diseases: a 25-year longitudinal study. J Infect Chemother. 2009;15:347–60.
- Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010;23:160–201.
- Refsdal AO. To treat or not to treat: a proper use of hormones and antibiotics. Anim Reprod Sci. 2000;60–61:109–19.
- Gould IM. The epidemiology of antibiotic resistance. Int J Antimicrob Agents. 2008;1:2–9.
- Demain AL. Antibiotics: natural products essential to human health. Med Res Rev. 2009;29:821–42.
- Butler MS. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep. 2008;25:475–516.
- Pantosi A, Venditti M. What is MRSA? Eur Respir J. 2009;34:1190–6.
- Giamarellou H, Poulakou G. Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs. 2009;69:1879–901.
- Devasahayam G, Scheld WM, Hoffman PS. Newer antibacterial drugs for a new century. Expert Opin Investig Drugs. 2010;19:215–34.
- Butler MS, Buss AD. Natural products — the future scaffolds for novel antibiotics? Biochem Pharmacol. 2006;71:919–29.
- Newman DJ. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? J Med Chem. 2008;51:2589–99.
- Dobson CM. Chemical space and biology. Nature. 2004;432:824–8.
- Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science. 2009;325:1089–93.
- Lee S, Atkins H, Duce I, Khan NA. Cockroach and locust: physicians’ answer to infectious diseases. Int J Antimicrob Agents. 2011;37:279–80.
- Khan NA, Osman K, Goldsworthy GJ. Lysates of locusta migratoria brain exhibit potent broad-spectrum antibacterial activity. J Antimicrob Chemother. 2008;62:634–5.
- Talbot GH, Bradley J, Edwards JE, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: an update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin Infect Dis. 2006;42:657–68.
- Clynen E, Schoots L. Peptidomic survey of the locust neuroendocrine system. Insect Biochem Mol Biol. 2009;39:491–507.
- Metz-Boutigue MH, Goumon Y, Strub JM, Lugardon K, Aunis D. Antimicrobial chromogranins and proenkephalin-A-derived peptides: antibacterial and antifungal activities of chromogranins and proenkephalin-A-derived peptides. Ann NY Acad Sci. 2003;992:168–78.
- Amiche M, Seon AA, Pierre TN, Nicolas P. The dermaseptin precursors: a protein family with a common preproregion and a variable C-terminal antimicrobial domain. FEBS Lett. 1999;456:352–6.
- Salzet M. Vertebrate innate immunity resembles a mosaic of invertebrate immune responses. Trends Immunol. 2001;22:285–8.